PharmGen Science Inc (004720) — Capital Reinvestment Ratio
PharmGen Science Inc (004720) has a Capital Reinvestment Ratio of 0.42x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.91 Billion) in capital expenditures (₩799.96 Million). Check PharmGen Science Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PharmGen Science Inc Capital Reinvestment Ratio (2011–2024)
This chart tracks PharmGen Science Inc's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of PharmGen Science Inc.
Annual Capital Reinvestment Ratio for PharmGen Science Inc (2011–2024)
Year-by-year Capital Reinvestment Ratio for PharmGen Science Inc from 2011 to 2024. See 004720 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | ₩2.38 Billion | ₩2.78 Billion | ▲ +92.9% |
| 2023 | 0.61x | ₩5.44 Billion | ₩3.29 Billion | ▼ -84.7% |
| 2021 | 3.95x | ₩7.78 Billion | ₩30.75 Billion | ▲ +143.6% |
| 2020 | 1.62x | ₩2.68 Billion | ₩4.34 Billion | ▼ -33.6% |
| 2019 | 2.44x | ₩2.52 Billion | ₩6.16 Billion | ▲ +1053.3% |
| 2018 | 0.21x | ₩4.22 Billion | ₩892.34 Million | ▼ -74.7% |
| 2017 | 0.84x | ₩1.84 Billion | ₩1.54 Billion | ▲ +88.9% |
| 2016 | 0.44x | ₩7.75 Billion | ₩3.43 Billion | ▲ +107.8% |
| 2015 | 0.21x | ₩3.62 Billion | ₩771.87 Million | ▼ -4.0% |
| 2011 | 0.22x | ₩2.89 Billion | ₩642.43 Million | — |